Title:
アデノシン誘導体を含む非アルコール性脂肪肝炎、肝線維症及び肝硬変症の予防及び治療用薬学的組成物
Document Type and Number:
Japanese Patent JP6912562
Kind Code:
B2
Abstract:
A pharmaceutical composition for preventing or treating liver disease is provided. The pharmaceutical composition comprising a compound represented by formula 1 below or a pharmaceutically acceptable salt of the compound as an active ingredient:where A is S, R is a linear or branched C-Calkyl which is non-substituted or is independently or selectively substituted with one or more C-Caryl groups, a benzyl which is non-substituted or is independently or selectively substituted with halogen or one or more linear or branched C-Calkoxy groups, or a hydroxycarbonyl-substituted benzyl, and Y is H or a halogen atom.
Inventors:
Isank
Park Jung Woo
Park Jung Woo
Application Number:
JP2019520614A
Publication Date:
August 04, 2021
Filing Date:
October 23, 2017
Export Citation:
Assignee:
FUTURE MEDICINE CO., LTD.
International Classes:
A61K31/7076; A61K9/14; A61K9/48; A61K47/10; A61K47/20; A61K47/38; A61P1/16
Domestic Patent References:
| JP2010520271A |
Other References:
Drug Discov Today,2012年,17(7-8),359-366
Br J Cancer,2003年,89(8),1552-1558
Br J Cancer,2003年,89(8),1552-1558
Attorney, Agent or Firm:
Kenji Sugimura
Mitsutsugu Sugimura
Mutsuya Yamamoto
Mitsutsugu Sugimura
Mutsuya Yamamoto